|
Volumn 57, Issue 9, 2001, Pages 1595-1602
|
A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CITICOLINE;
FREE RADICAL;
PLACEBO;
ADULT;
AGED;
ARTICLE;
CELL MEMBRANE;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MIDDLE CEREBRAL ARTERY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
TREATMENT OUTCOME;
|
EID: 0035856456
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/WNL.57.9.1595 Document Type: Article |
Times cited : (167)
|
References (30)
|